Synageva Biopharma Corp.
Historical 13F Holders
Symbol
GEVA
CUSIP
87159A103
All holders as of
Q1 2015
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings
Period
Filings
Shares, Excl. Options
Value, Excl. Options
Options Value
2015 Q1
144
39.9 M
$3.89 B
$82.7 M
2014 Q4
134
36.6 M
$3.39 B
$21.4 M
2014 Q3
125
35.5 M
$2.44 B
$11.9 M
2014 Q2
131
34.3 M
$3.60 B
$75.7 M
2014 Q1
121
32.3 M
$2.68 B
$34.2 M